The £1 Pill That Could Transform Cancer CareHow low-dose aspirin halves colorectal cancer recurrence for patients with key genetic mutationsAmer AltafOct 04, 2025∙ Paid1ShareWhy it mattersA single daily tablet costing less than 10p has delivered one of the most remarkable breakthroughs in modern oncology. The ALASCCA trial, published in the New England Journal of MedicineContinue reading this post for free, courtesy of Amer Altaf.Claim my free postOr purchase a paid subscription.PreviousNext